Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anhydrous crystalline free base form of 6-{2-[1 -(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole

Anhydrous crystalline free base form of 6-{2-[1 -(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole

US Patent 9802926 · Granted Oct 31, 2017

Estimated economic value: $462,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Injectable triamcinolone formulations2025
Reduction of flake-like aggregation in nanoparticulate active agent compositions2023
Reduction of flake-like aggregation in nanoparticulate active agent compositions2022
Pharmaceutical formulations2020
Reduction of flake-like aggregation in nanoparticulate active agent compositions2018
Reduction of flake-like aggregation in nanoparticulate active agent compositions2018
Reduction of flake-like aggregation in nanoparticulate active agent compositions2018
Pharmaceutical formulations2018
Pharmaceutical formulations2016
Reduction of flake-like aggregation in nanoparticulate active agent compositions2016
Antibody treatment of Alzheimer's and related diseases2015
Starch-based corrugating adhesive containing fibers1990